Is VTRLY or BTI a better dividend investment in 2026?

VTRLY currently yields 1.09% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: BTI offers higher current income.

What is the dividend yield difference between VTRLY and BTI?

VTRLY has a forward dividend yield of 1.09% ($0.12/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 4.29 percentage points.

Home › Compare › VTRLY vs BTI

VTRLY vs BTI: Dividend Comparison 2026

VTRLY yields 1.09% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BTI wins by $16.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

VTRLY

● Live price

1.09%

Share price

$11.00

Annual div

$0.12

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.2K

Annual income

$117.09

Full VTRLY calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — VTRLY vs BTI

📍 BTI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VTRLY	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VTRLY + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VTRLY pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VTRLY

Annual income on $10K today (after 15% tax)

$92.73/yr

After 10yr DRIP, annual income (after tax)

$99.53/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, BTI beats the other by $2,269.12/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VTRLY + BTI for your $10,000?

VTRLY: 50%BTI: 50%

100% BTI50/50100% VTRLY

Portfolio after 10yr

$29.5K

Annual income

$1,451.87/yr

Blended yield

4.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

VTRLY

No analyst data

Altman Z

0.8

Piotroski

5/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VTRLY buys

BTI buys

No recent congressional trades found for VTRLY or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVTRLYBTI

Forward yield	1.09%	5.38% ✓
Annual dividend / share	$0.12	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$21.2K	$37.7K ✓
Annual income after 10y	$117.09	$2,786.64 ✓
Total dividends collected	$1.1K	$14.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: VTRLY vs BTI ($10,000, DRIP)

Year	VTRLY Portfolio	VTRLY Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$10,809	$109.09	$11,299	$598.92	$490.00 → BTI
2	$11,676	$110.20	$12,794	$703.91	$1.1K → BTI
3	$12,604	$111.25	$14,518	$829.07	$1.9K → BTI
4	$13,599	$112.24	$16,513	$978.64	$2.9K → BTI
5	$14,664	$113.18	$18,827	$1,157.84	$4.2K → BTI
6	$15,805	$114.06	$21,518	$1,373.12	$5.7K → BTI
7	$17,026	$114.89	$24,657	$1,632.46	$7.6K → BTI
8	$18,333	$115.67	$28,329	$1,945.74	$10.0K → BTI
9	$19,733	$116.40	$32,637	$2,325.33	$12.9K → BTI
10	$21,232	$117.09	$37,708	$2,786.64	$16.5K → BTI

VTRLY vs BTI: Complete Analysis 2026

VTRLY — Stock

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.

Full VTRLY Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this VTRLY vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VTRLY vs SCHD VTRLY vs JEPI VTRLY vs O VTRLY vs KO VTRLY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.